呼吸器合胞体ウイルス(RSV)治療薬の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE3993)
◆英語タイトル:Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3993
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:95
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、呼吸器合胞体ウイルス(RSV)治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(パリビズマブ、リバビリン、その他)、用途別市場規模(病院薬局、ドラッグストア、小売薬局、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・呼吸器合胞体ウイルス(RSV)治療薬の市場動向
・企業の競争状況、市場シェア
・呼吸器合胞体ウイルス(RSV)治療薬の種類別市場規模(パリビズマブ、リバビリン、その他)
・呼吸器合胞体ウイルス(RSV)治療薬の用途別市場規模(病院薬局、ドラッグストア、小売薬局、その他)
・呼吸器合胞体ウイルス(RSV)治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・呼吸器合胞体ウイルス(RSV)治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・呼吸器合胞体ウイルス(RSV)治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・呼吸器合胞体ウイルス(RSV)治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・呼吸器合胞体ウイルス(RSV)治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Roche、AstraZeneca、Merck、AbbVie、Bausch Health、GlaxoSmithKline、ReViral、Gilead Sciences、Teva Pharmaceutical)
・結論
【レポートの概要】

Market Analysis and Insights: Global Respiratory Syncytial Virus(RSV) Therapeutics Market
The global Respiratory Syncytial Virus(RSV) Therapeutics market size is projected to reach US$ 837.5 million by 2027, from US$ 564.7 million in 2020, at a CAGR of 5.7% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Respiratory Syncytial Virus(RSV) Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Respiratory Syncytial Virus(RSV) Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Respiratory Syncytial Virus(RSV) Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Respiratory Syncytial Virus(RSV) Therapeutics market.

Global Respiratory Syncytial Virus(RSV) Therapeutics Scope and Market Size
Respiratory Syncytial Virus(RSV) Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Syncytial Virus(RSV) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Sale Channel in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Palivizumab
Ribavirin
Others

Segment by Sale Channel
Hospital Pharmacies
Drug Stores
Retail Pharmacies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
AstraZeneca
Merck
AbbVie
Bausch Health
GlaxoSmithKline
ReViral
Gilead Sciences
Teva Pharmaceutical

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Palivizumab
1.2.3 Ribavirin
1.2.4 Others
1.3 Market by Application
1.3.1 Global Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Sale Channel: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Respiratory Syncytial Virus(RSV) Therapeutics Market Perspective (2016-2027)
2.2 Respiratory Syncytial Virus(RSV) Therapeutics Growth Trends by Regions
2.2.1 Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Respiratory Syncytial Virus(RSV) Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Respiratory Syncytial Virus(RSV) Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Respiratory Syncytial Virus(RSV) Therapeutics Industry Dynamic
2.3.1 Respiratory Syncytial Virus(RSV) Therapeutics Market Trends
2.3.2 Respiratory Syncytial Virus(RSV) Therapeutics Market Drivers
2.3.3 Respiratory Syncytial Virus(RSV) Therapeutics Market Challenges
2.3.4 Respiratory Syncytial Virus(RSV) Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Respiratory Syncytial Virus(RSV) Therapeutics Players by Revenue
3.1.1 Global Top Respiratory Syncytial Virus(RSV) Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Respiratory Syncytial Virus(RSV) Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Respiratory Syncytial Virus(RSV) Therapeutics Revenue
3.4 Global Respiratory Syncytial Virus(RSV) Therapeutics Market Concentration Ratio
3.4.1 Global Respiratory Syncytial Virus(RSV) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Syncytial Virus(RSV) Therapeutics Revenue in 2020
3.5 Respiratory Syncytial Virus(RSV) Therapeutics Key Players Head office and Area Served
3.6 Key Players Respiratory Syncytial Virus(RSV) Therapeutics Product Solution and Service
3.7 Date of Enter into Respiratory Syncytial Virus(RSV) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Respiratory Syncytial Virus(RSV) Therapeutics Breakdown Data by Type
4.1 Global Respiratory Syncytial Virus(RSV) Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Respiratory Syncytial Virus(RSV) Therapeutics Forecasted Market Size by Type (2022-2027)

5 Respiratory Syncytial Virus(RSV) Therapeutics Breakdown Data by Sale Channel
5.1 Global Respiratory Syncytial Virus(RSV) Therapeutics Historic Market Size by Sale Channel (2016-2021)
5.2 Global Respiratory Syncytial Virus(RSV) Therapeutics Forecasted Market Size by Sale Channel (2022-2027)

6 North America
6.1 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size (2016-2027)
6.2 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type
6.2.1 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2027)
6.3 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel
6.3.1 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2021)
6.3.2 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2022-2027)
6.3.3 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2027)
6.4 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country
6.4.1 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size (2016-2027)
7.2 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type
7.2.1 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2027)
7.3 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel
7.3.1 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2021)
7.3.2 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2022-2027)
7.3.3 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2027)
7.4 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country
7.4.1 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type
8.2.1 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel
8.3.1 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2021)
8.3.2 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2022-2027)
8.3.3 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2027)
8.4 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Region
8.4.1 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size (2016-2027)
9.2 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type
9.2.1 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel
9.3.1 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2021)
9.3.2 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2022-2027)
9.3.3 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2027)
9.4 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country
9.4.1 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type
10.2.1 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel
10.3.1 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2021)
10.3.2 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2022-2027)
10.3.3 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2027)
10.4 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country
10.4.1 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.1.4 Roche Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.1.5 Roche Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.2.4 AstraZeneca Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.3.4 Merck Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.3.5 Merck Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.4.4 AbbVie Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.4.5 AbbVie Recent Development
11.5 Bausch Health
11.5.1 Bausch Health Company Details
11.5.2 Bausch Health Business Overview
11.5.3 Bausch Health Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.5.4 Bausch Health Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.5.5 Bausch Health Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.6.4 GlaxoSmithKline Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 ReViral
11.7.1 ReViral Company Details
11.7.2 ReViral Business Overview
11.7.3 ReViral Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.7.4 ReViral Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.7.5 ReViral Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.8.4 Gilead Sciences Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.8.5 Gilead Sciences Recent Development
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Details
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.9.4 Teva Pharmaceutical Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.9.5 Teva Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 呼吸器合胞体ウイルス(RSV)治療薬の世界市場規模・現状・予測2021年-2027年(Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。